Emergence Therapeutics

Duisburg, Germany

Emergence is a biopharmaceutical company working on novel ADC immunotherapies for cancers with a high unmet need.

Dec 2021

Series A

Biotechnology Fitness Health Care Wellness

Top Investors

RA Capital ManagementBpifranceHTGF (High-Tech Gruenderfonds)NRW.BANKOrbiMed

Founder Contacts

19,000+ verified contacts

Get Instant Access

Emails, phones & LinkedIn profiles

Frequently Asked Questions about Emergence Therapeutics

Who are Emergence Therapeutics's investors?

Emergence Therapeutics's investors include RA Capital Management, Bpifrance, HTGF (High-Tech Gruenderfonds), NRW.BANK, OrbiMed.

Where is Emergence Therapeutics headquartered?

Emergence Therapeutics is headquartered in Duisburg, Germany.

What does Emergence Therapeutics do?

Emergence is a biopharmaceutical company working on novel ADC immunotherapies for cancers with a high unmet need.

What stage is Emergence Therapeutics at?

Emergence Therapeutics is at the Series A stage.

Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated December 7, 2021.

MLA

"Emergence Therapeutics — Funding & Investors." VCBacked, December 7, 2021, https://www.vcbacked.co/company/emergence-therapeutics. Accessed July 1, 2026.

APA

VCBacked. (2021). Emergence Therapeutics — Funding & Investors. Retrieved July 1, 2026, from https://www.vcbacked.co/company/emergence-therapeutics

Wikipedia (cite web)

{{cite web |title=Emergence Therapeutics — Funding & Investors |url=https://www.vcbacked.co/company/emergence-therapeutics |website=VCBacked |access-date=July 1, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated December 7, 2021.